Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應用
N-(2-Chloro-4-pyrimidinyl)-2,3-dimethyl-2H-indazol-6-amine is an impurity of Pazopanib (P210925), an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
參考文獻
Li, Y., et al.: J. Pharma. Biomed. Anal., 52, 493 (2010); Harris, P.A., et al.: J. Med. Chem., 51, 4632 (2008); Liu, D.Q., et al.: Character. Impurities. Degrad. Mass. Spec., 251 (2011);